Research & Development



  “耶耶說不能隨便給別人下跪。”   雲瑯停下手里的活計想了一下道︰“我還真的答應過你父親收你為雲氏家臣。你不用說什麼,直接回去告訴卓姬,賣掉卓氏鐵坊,不要再有任何幻想了,孔僅已經倒霉了,所以啊,現在基本上沒有鐵器商人的活路了,以後,所有的鐵器都需要官賣。我想,卓姬應該沒有充當官府店鋪掌櫃的心力吧?”500万彩票软件下载   “耶耶說不能隨便給別人下跪。”皇家娱乐彩票软件下载   “看樣子,一個孩子才是雲瑯最想要的……”衛青背著手站在大門外,看著雲瑯朝長安方向行叩拜大禮!   他也覺得這種娶老婆的法子其實很靠譜,只要去掉無用的感情,男子在用木棒求婚的過程中不但展現了自己的勇猛,狡獪,以及靈活的身手,甚至連智慧也在敲暈女子的那一瞬間得到了全面的展現。彩票软件下载安卓版   雲瑯一個人坐在高台上,眼看著夕陽慢慢的落山,眼看著驪山被黑夜漸漸地吞沒,眼看著雲氏燈火輝煌。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo